Mark S Duncan
Nursing at Joplin Way, Denver, CO
License number
Colorado 150420
Issued Date
Mar 8, 1990
Renew Date
Jan 31, 1992
Expiration Date
Jan 31, 1992
Type
Certified Nurse Aide
Address
Address
2
3954 S Joplin Way S JOPLIN WAY, Denver, CO 80013
Denver, CO
Denver, CO
Professional information
Professor At Uc Denver
Position:
Professor at UC Denver, Director of Academic Collaborations at Biodesix, Inc.
Location:
Greater Denver Area
Industry:
Higher Education
Work:
UC Denver
-
Professor
Biodesix, Inc.
since 2010
-
Director of Academic Collaborations
Professor At University Of Colorado Health Sciences Center
Position:
Professor at University of Colorado Health Sciences Center
Location:
Greater Denver Area
Industry:
Research
Work:
University of Colorado Health Sciences Center
-
Professor
Biomarkers For Diagnosis Of Breast Cancer
US Patent:
2011020, Aug 25, 2011
Filed:
Oct 29, 2009
Appl. No.:
13/126772
Inventors:
Mark W. Duncan - Denver CO, US
Lindsay Weitzel - Denver CO, US
Anthony Elias - Denver CO, US
Timothy Byers - Arvada CO, US
Lindsay Weitzel - Denver CO, US
Anthony Elias - Denver CO, US
Timothy Byers - Arvada CO, US
Assignee:
The Regents of the University of Colorado - Denver CO
International Classification:
G01N 33/53
US Classification:
435 792
Abstract:
The present invention provides methods and kits for determining breast cancer. The invention includes the identification and use of biomarkers that are present in different amount or differentially expressed in breast cancer versus normal controls.
Quantitative Analysis Of Protein Isoforms Using Matrix-Assisted Laser Desorption/Ionization Time Of Flight Mass Spectrometry
US Patent:
2004011, Jun 24, 2004
Filed:
Oct 30, 2003
Appl. No.:
10/697991
Inventors:
M. Perryman - Garretson SD, US
Steve Helmke - Denver CO, US
Mark Duncan - Denver CO, US
Steve Helmke - Denver CO, US
Mark Duncan - Denver CO, US
Assignee:
The Regents of the University of Colorado
International Classification:
H01J049/00
US Classification:
250/281000
Abstract:
The present invention provides for methods of quantitating the amounts of proteins or peptides, including those that are closely related isoforms, using matrix-assisted laser desorption/ionization time of flight mass spectrometry (MALDI-TOF-MS). Measurement of protein concentrations in vivo has been extremely difficult and problematic, and protein concentrations have not been shown to correlate well with mRNA levels, the standard used in the past. The present invention overcomes the deficiencies of prior methodologies by taking advantage of MALDI-TOF-MS technology and applying it to proteins and peptides in a way that allows for accurate, quantitative measurement in vivo of protein or peptide concentrations.
Method For Protein Identification From Tandem Mass Spectral Employing Both Spectrum Comparison And De Novo Sequencing For Biomedical Applications
US Patent:
2005007, Apr 7, 2005
Filed:
Jul 7, 2004
Appl. No.:
10/886779
Inventors:
Mark Duncan - Denver CO, US
Srdjan Askovic - Salt Lake City UT, US
Kim Fung - New South Wales, AU
Srdjan Askovic - Salt Lake City UT, US
Kim Fung - New South Wales, AU
International Classification:
G01N033/53, G06F019/00, G01N033/48, G01N033/50
US Classification:
435007100, 702019000
Abstract:
A method and algorithm for identifying a protein sequence from mass spectral data combines peptide spectrum matching analysis or spectrum comparison approaches and de novo sequencing approaches. The algorithm of the invention identifies peptide sequences determined independently by each approach, then compares the results and assigns a score reflecting the “goodness” of the match with a full-length protein sequence. Because peptides are identified using independent approaches, the probability of a correct match is increased.
Biomarkers For Follicular Thyroid Carcinoma And Methods Of Use
US Patent:
8455208, Jun 4, 2013
Filed:
Apr 14, 2008
Appl. No.:
12/596196
Inventors:
Stephen W. Hunsucker - Broomfield CO, US
Bryan R. Haugen - Englewood CO, US
Mark W. Duncan - Denver CO, US
Romana Teodora Maier - Nijmegen, NL
Bryan R. Haugen - Englewood CO, US
Mark W. Duncan - Denver CO, US
Romana Teodora Maier - Nijmegen, NL
Assignee:
The Regents of the University of Colorado - Denver CO
International Classification:
G01N 33/574
US Classification:
435 723, 435 71, 435 74
Abstract:
The present invention provides protein biomarkers for determining whether a thyroid nodule is malignant or benign and methods for using the same.
Biomarkers For Babesia
US Patent:
2009021, Aug 27, 2009
Filed:
Dec 12, 2006
Appl. No.:
12/097037
Inventors:
Momar Ndao - La Prairie, CA
Brian Ward - Montreal, CA
Peter Krause - Hartford CT, US
Mark W. Duncan - Denver CO, US
Mike Edwards - Denver CO, US
Terence William Spithill - Notre Dame D'lle Perrot, CA
Brian Ward - Montreal, CA
Peter Krause - Hartford CT, US
Mark W. Duncan - Denver CO, US
Mike Edwards - Denver CO, US
Terence William Spithill - Notre Dame D'lle Perrot, CA
International Classification:
G01N 33/569
US Classification:
435 722
Abstract:
The present invention provides protein-based biomarkers and biomarker combinations that are useful in qualifying babesia status in a patient. In particular, the biomarkers of this invention are useful to classify a subject sample as infected with babesia or not infected with babesia. The biomarkers can be detected by SELDI mass spectrometry.